Literature DB >> 11486904

Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27).

S Sugama1, A Kimura, W Chen, S Kubota, Y Seyama, N Taira, Y Eto.   

Abstract

Of the primary dementing disorders that cause frontotemporal dementia, the best-known is Pick disease. We report on a 44-year-old woman with progressive frontal lobe dementia and spastic paraplegia. Examination revealed increased serum levels of cholestanol with abnormal cholesterol metabolism and a heterozygous mutation of the sterol 27-hydroxylase gene (CYP27). Biochemical findings were compatible with cerebrotendinous xanthomatosis (CTX); however, the clinical manifestations were very dissimilar. To our knowledge, a symptomatic carrier of this mutation among CTX patients has not been reported. We speculate that the present patient has a previously undescribed neurodegenerative disease related to abnormal cholesterol metabolism with this heterozygous mutation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11486904     DOI: 10.1023/a:1010564920930

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  28 in total

1.  Determination of 3-oxo-delta4- and 3-oxo-delta4,6-bile acids and related compounds in biological fluids of infants with cholestasis by gas chromatography-mass spectrometry.

Authors:  M Suzuki; T Murai; T Yoshimura; A Kimura; T Kurosawa; M Tohma
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-05-23

2.  Novel homozygous and compound heterozygous mutations of sterol 27-hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three Japanese patients from two unrelated families.

Authors:  W Chen; S Kubota; K S Kim; J Cheng; M Kuriyama; G Eggertsen; I Björkhem; Y Seyama
Journal:  J Lipid Res       Date:  1997-05       Impact factor: 5.922

3.  Profile of urinary bile acids in infants and children: developmental pattern of excretion of unsaturated ketonic bile acids and 7beta-hydroxylated bile acids.

Authors:  A Kimura; R Mahara; T Inoue; Y Nomura; T Murai; T Kurosawa; M Tohma; K Noguchi; A Hoshiyama; T Fujisawa; H Kato
Journal:  Pediatr Res       Date:  1999-04       Impact factor: 3.756

4.  Presenile dementia with motor neuron disease in Japan. A new entity?

Authors:  Y Mitsuyama; S Takamiya
Journal:  Arch Neurol       Date:  1979-09

5.  Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis.

Authors:  J J Cali; C L Hsieh; U Francke; D W Russell
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

Review 6.  Clinical features of frontal lobe dementia in comparison to Alzheimer's disease.

Authors:  C A Gregory; J R Hodges
Journal:  J Neural Transm Suppl       Date:  1996

7.  Depression in a patient with dementia secondary to cerebrotendinous xanthomatosis.

Authors:  S Shapiro
Journal:  J Nerv Ment Dis       Date:  1983-09       Impact factor: 2.254

8.  Identification of new mutations in sterol 27-hydroxylase gene in Japanese patients with cerebrotendinous xanthomatosis (CTX).

Authors:  K S Kim; S Kubota; M Kuriyama; J Fujiyama; I Björkhem; G Eggertsen; Y Seyama
Journal:  J Lipid Res       Date:  1994-06       Impact factor: 5.922

9.  Differential diagnosis of presenile dementia on clinical grounds.

Authors:  L Gustafson; L Nilsson
Journal:  Acta Psychiatr Scand       Date:  1982-03       Impact factor: 6.392

10.  Serum bile acid profiles in cerebrotendinous xanthomatosis.

Authors:  T Beppu; Y Seyama; T Kasama; S Serizawa; T Yamakawa
Journal:  Clin Chim Acta       Date:  1982-02-05       Impact factor: 3.786

View more
  12 in total

1.  Cerebrotendinous xanthomatosis: neuropathological findings.

Authors:  B Pilo de la Fuente; I Ruiz; A Lopez de Munain; A Jimenez-Escrig
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 4.849

2.  Common genetic etiology between "multiple sclerosis-like" single-gene disorders and familial multiple sclerosis.

Authors:  Anthony L Traboulsee; A Dessa Sadovnick; Mary Encarnacion; Cecily Q Bernales; Irene M Yee; Maria G Criscuoli; Carles Vilariño-Güell
Journal:  Hum Genet       Date:  2017-03-23       Impact factor: 4.132

3.  A novel frameshift mutation in the sterol 27-hydroxylase gene in an Egyptian family with cerebrotendinous xanthomatosis without cataract.

Authors:  Mohamed S Abdel-Hamid; Mahmoud Y Issa; Ghada A Otaify; Maha S Zaki
Journal:  Metab Brain Dis       Date:  2017-02-22       Impact factor: 3.584

4.  Cerebrotendinous xanthomatosis: a rare genetic disorder.

Authors:  Rohan Arjun Bhojwani; Rajashree Khot
Journal:  BMJ Case Rep       Date:  2011-09-05

5.  NGS-driven molecular diagnosis of heterogeneous hereditary neurological disorders reveals novel and known variants in disease-causing genes.

Authors:  Ayaz Khan; Shixiong Tian; Muhammad Tariq; Sheraz Khan; Muhammad Safeer; Naimat Ullah; Nazia Akbar; Iram Javed; Mahnoor Asif; Ilyas Ahmad; Shahid Ullah; Humayoon Shafique Satti; Raees Khan; Muhammad Naeem; Mahwish Ali; John Rendu; Julien Fauré; Klaus Dieterich; Xenia Latypova; Shahid Mahmood Baig; Naveed Altaf Malik; Feng Zhang; Tahir Naeem Khan; Chunyu Liu
Journal:  Mol Genet Genomics       Date:  2022-08-24       Impact factor: 2.980

6.  Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration.

Authors:  Maria K Tsaousidou; Karim Ouahchi; Tom T Warner; Yi Yang; Michael A Simpson; Nigel G Laing; Philip A Wilkinson; Ricardo E Madrid; Heema Patel; Faycal Hentati; Michael A Patton; Afif Hentati; Philippa J Lamont; Teepu Siddique; Andrew H Crosby
Journal:  Am J Hum Genet       Date:  2008-01-18       Impact factor: 11.025

7.  Cholestenoic acids regulate motor neuron survival via liver X receptors.

Authors:  Spyridon Theofilopoulos; William J Griffiths; Peter J Crick; Shanzheng Yang; Anna Meljon; Michael Ogundare; Satish Srinivas Kitambi; Andrew Lockhart; Karin Tuschl; Peter T Clayton; Andrew A Morris; Adelaida Martinez; M Ashwin Reddy; Andrea Martinuzzi; Maria T Bassi; Akira Honda; Tatsuki Mizuochi; Akihiko Kimura; Hiroshi Nittono; Giuseppe De Michele; Rosa Carbone; Chiara Criscuolo; Joyce L Yau; Jonathan R Seckl; Rebecca Schüle; Ludger Schöls; Andreas W Sailer; Jens Kuhle; Matthew J Fraidakis; Jan-Åke Gustafsson; Knut R Steffensen; Ingemar Björkhem; Patrik Ernfors; Jan Sjövall; Ernest Arenas; Yuqin Wang
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

Review 8.  Psychiatric manifestations in cerebrotendinous xanthomatosis.

Authors:  M J Fraidakis
Journal:  Transl Psychiatry       Date:  2013-09-03       Impact factor: 6.222

9.  The wide genetic landscape of clinical frontotemporal dementia: systematic combined sequencing of 121 consecutive subjects.

Authors:  Cornelis Blauwendraat; Carlo Wilke; Javier Simón-Sánchez; Iris E Jansen; Anika Reifschneider; Anja Capell; Christian Haass; Melissa Castillo-Lizardo; Saskia Biskup; Walter Maetzler; Patrizia Rizzu; Peter Heutink; Matthis Synofzik
Journal:  Genet Med       Date:  2017-07-27       Impact factor: 8.822

10.  Bilateral Xanthomas of Tendoachilles in A Patient of Cerebrotendinous Xanthomatosis - A Rare Case Report and Review of Literature.

Authors:  Vrk Sastri; V S Ravindranath; Sreenivasulu Metikala; Madhusudhan Kumar
Journal:  J Orthop Case Rep       Date:  2014 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.